<DOC>
	<DOCNO>NCT00286962</DOCNO>
	<brief_summary>The purpose study compare intraperitoneal ( IP ) therapy subcutaneous administration insulin regard safety , glycemic control number episode hypoglycemia patient type 1 diabetes mellitus .</brief_summary>
	<brief_title>Study Compare Intraperitoneal Insulin Subcutaneous Insulin Administration Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Various study data available suggest intraperitoneal ( IP ) delivery insulin type 1 type 2 diabetic subject provide appropriate therapy allow subject achieve acceptable glycemic control without increase inherent risk severe hypoglycemia observe intensive insulin treatment pursue . Up till little research do investigate efficacy intraperitoneal ( IP ) therapy compare subcutaneous administration . In study aim safety non-inferiority superiority IP therapy concern glycemic control less episodes hypoglycemia compare intensive subcutaneous ( SC ) therapy intermediate poorly control Type 1 patient and/or patient frequent severe hypoglycemic event . Subjects randomized insulin treatment use Medtronic Minimed Implantable Pump subcutaneous insulin therapy first study arm . After first arm study , subject cross second arm receive treatment whichever receive first treatment phase . Subjects MIP already implant retain pump receive diluent intraperitoneally second study arm .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes mellitus Intermediate poor glycemic control , define HbA1c ≥ 7,5 % AND/OR ≥ 5 incident hypoglycemia week . renal function impairment : creatinin ≥ 150 micromol/L creatinin clearance &lt; 50 ml/min Cardiac problem : decompensated heart failure ( NYHA III IV ) ; diagnosis unstable angina pectoris ; myocardial infarction within last 12 month Known suspected allergy insulin component composition Mental retardation psychiatric treatment schizophrenia , organic mental disorder bipolar disorder currently past . Severe untreated proliferative retinopathy . Insufficient knowledge Dutch language understand requirement study . Current use systemic corticosteroid suffer condition cause systemic corticosteroid use last year . Substance abuse , nicotine A history cancer , exclude well differentiate thyroid carcinoma , breast carcinoma without lymph node metastasis skin carcinoma Participation trial , involve investigational product within 30 day prior trial entry . Plans engage activity require go 25 foot sea level . Any condition Investigator and/or Coordinating Investigator feel would interfere trial participation evaluation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Diabetes mellitus , type 1</keyword>
	<keyword>insulin infusion system</keyword>
	<keyword>continuous intraperitoneal insulin infusion</keyword>
	<keyword>cross-over study</keyword>
</DOC>